Clinical Trials on Fallopian Cancer in Finland

Total 1294 results

ImmunoGen, Inc.

Active, not recruiting

Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States, France, Belgium, Spain, Ireland, Italy, Australia, Canada
Turku University Hospital

Recruiting

Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancer (NeoADT-TULSA)

Prostate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate Cancer

Finland
National Cancer Institute (NCI)
NRG Oncology

Withdrawn

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditions

United States
Turku University Hospital
Nordic Urothelial Cancer Group

Recruiting

Nordic Cystectomy Study III - Transfusion (NorCys-Transf)

Bladder Cancer | Invasive Bladder Cancer

Finland
Turku University Hospital
Nordic Urothelial Cancer Group

Recruiting

Nordic Cystectomy Study I - Neutrophil-lymphocyte Ratio (NLR) (NorCys-NLR)

Bladder Cancer | Invasive Bladder Cancer

Finland
Turku University Hospital
Turku AMK Master School

Completed

Exercise Intervention for Cancer Patients

Cancer

Finland
Turku University Hospital
Nordic Urothelial Cancer Group

Recruiting

Nordic Cystectomy Study II - Albumin (NorCys-Alb)

Bladder Cancer | Invasive Bladder Cancer

Finland
National Cancer Institute (NCI)
NRG Oncology

Completed

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous... and other conditions

United States
Janssen Research & Development, LLC
PharmaMar

Completed

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

United States, Poland, United Kingdom, China, Switzerland, Israel, South Africa, Australia, Russian Federation, New Zealand
Turku University Hospital
Lounais-Suomen Syöpäyhdistys

Not yet recruiting

Fit for Everyday Life - Increasing Exercise and Physical Activity in Those Rehablilitating From Cancer

Cancer Survivor

Finland
Heikki Joensuu

Terminated

Effects of S-1 and Capecitabine on Coronary Artery Blood Flow (FluoHeart)

Stomach Cancer | Small Bowel Cancer | Colon Cancer | Esophagus Cancer | Rectum Cancer

Finland
Pfizer

Completed

A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Kidney Cancer | Kidney Neoplasms | Renal Cell Carcinoma | Renal Cancer | Renal Cell Cancer | Cancer of the Kidney | Cancer of Kidney

Finland
Oulu University Hospital

Unknown

Follow-up of Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy by Electronic Patient Reported Outcomes-tool

Cancer

Finland
Oulu University Hospital

Unknown

Electronic Symptom Follow-up of Cancer Patients

Cancer

Finland
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Collecting Tumor Samples From Patients With Gynecological Tumors

Melanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditions

United States
National Cancer Institute (NCI)
NRG Oncology

Completed

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma

United States
Turku University Hospital
University of Turku; Tampere University Hospital

Completed

Active Video Games to Promote Physical Activity in Children With Cancer

Cancer

Finland
Turku University Hospital
University of Turku

Active, not recruiting

MRI Guided Transurethral HIFU for Various Prostate Diseases (HIFU-PRO)

Benign Prostatic Hyperplasia | Locally Advanced Prostate Cancer | Locally Recurrent Prostate Cancer | Localised Prostate Cancer

Finland
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Malignant Ovarian Endometrioid Tumor | Ovarian High Grade Serous Adenocarcinoma | Platinum-Sensitive Ovarian Carcinoma | Fallopian Tube High Grade Serous Adenocarcinoma and other conditions

United States
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Fallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditions

United States, Japan
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

Fallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditions

United States
AstraZeneca

Completed

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

Non-Metastatic Prostate Cancer

Finland
Elucida Oncology

Recruiting

A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Ovarian Diseases | Ovarian Neoplasms | Ovarian Cancer | Ovarian Epithelial Cancer | Fallopian Tube Cancer | Endometrial Neoplasms | Endometrial Cancer | Endometrial Clear Cell Adenocarcinoma | Ovarian Carcinoma | Endometrial Adenocarcinoma | Peritoneal Cancer | Endometrioid Adenocarcinoma | Ovarian Adenocarcinoma | Ovarian Serous Adenocarcinoma and other conditions

United States
Tampere University Hospital
Turku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaborators

Completed

Second-line Chemotherapy in Castration Resistant Prostate Cancer (ProstyII)

Metastatic Prostate Cancer

Finland
Joint Authority for Päijät-Häme Social and Health...
Kanta-Häme Central Hospital

Recruiting

Laparoscopic Approach for Emergency Colon Resection

Laparoscopic Surgery | Emergencies | Colorectal Cancer | Colorectal Disorders | Complication of Surgical Procedure | Long-term Effects of Cancer Treatment

Finland
Pia Osterlund

Recruiting

Study of Bevacizumab in Combination With Alternating Xeliri and Xelox in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Finland
Tampere University
Finnish Prostate Cancer Group

Unknown

FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

Patients With T1-4 Advanced Prostate Cancer

Finland
Pia Osterlund

Recruiting

A Population-based Prospective Study of Metastatic Colorectal Cancer (CRC) Patients in Finland (RAXO)

Metastatic Colorectal Cancer

Finland
Helsinki University Central Hospital
University of Helsinki; University of Eastern Finland

Unknown

Intensive Nutrition Counselling in Patients With Head and Neck Cancer

Head and Neck Squamous Cell Cancer

Finland
Pfizer

Completed

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Metastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Finland
Turku University Hospital

Unknown

Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers (IMPROD2_0)

Prostate Cancer

Finland
Turku University Hospital
University of Turku

Completed

Novel Imaging in Staging of Primary Prostate Cancer (PROSTAGE)

High Risk Prostate Cancer

Finland
CanariaBio Inc.
Gynecologic Oncology Group; Iqvia Pty Ltd

Active, not recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5)

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Peritoneal Carcinoma | Peritoneal Cancer | Fallopian Tube Adenocarcinoma | Fallopian Tube Serous Adenocarcinoma | Ovarian Serous Adenocarcinoma

Korea, Republic of, United States, Taiwan, Czechia, Argentina, Spain, Belgium, Brazil, Chile, Canada, Italy, Hungary, India, Mexico
Turku University Hospital

Active, not recruiting

Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer (PRO-TULSA-PC)

Localized Prostate Cancer

Finland
Helsinki University Central Hospital

Completed

Feasibility of Ambulatory Surgery for Early Breast Cancer

Early Breast Cancer | Ambulatory Surgery | Psychosocial Wellbeing

Finland
Boneca Corporation

Completed

Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors

Head and Neck Cancer

Finland
Tampere University Hospital
University of Turku; University of Helsinki; Tampere University; Aalto University

Recruiting

Measuring Oncological Value of Exercise and Statin (MOVES)

Kidney Cancer | Breast Cancer | Metastatic Renal Cell Carcinoma | Ovarian Cancer | Prostate Cancer | Metastatic Breast Cancer | Metastatic Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Ovarian Cancer | Metastatic Renal Cancer | Metastatic Kidney Cancer | Metastatic Ovary Cancer

Finland
Turku University Hospital

Recruiting

99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer

Prostate Cancer

Finland
Tampere University Hospital
Tampere University

Not yet recruiting

Targeted Radiotherapy for Recurrent Prostate Cancer (TASTEPRO)

Prostate Cancer Recurrence After Radical Prostatectomy

Finland
Oulu University Hospital

Active, not recruiting

LDCT-SC-FI Low-dose CT Screening for Lung Cancer

Lung Cancer Screening

Finland
Tampere University Hospital

Completed

Intraoperative Tissue Identification by Analyzing Surgical Smoke (SurgiNose)

Breast Cancer

Finland
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Ovarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditions

United States, Puerto Rico
Helsinki University Central Hospital
Institute for Molecular Medicine

Unknown

Circulating DNA in Surgically Treated NSCLC

Non-small Cell Lung Cancer

Finland
Turku University Hospital

Completed

PET-CT in Diagnosis of Pancreatic Cystic Neoplasms

Neoplasms | Pancreatic Cancer

Finland
Helsinki University Central Hospital
Karolinska Institutet

Recruiting

Development of Diagnostics and Treatment of Urological Cancers (DEDUCER)

Kidney Cancer | Urothelial Carcinoma | Prostate Carcinoma | Penile Cancer | Testicular Cancer

Finland
ppharmaand GmbH
Bristol-Myers Squibb; Gynecologic Oncology Group; European Network of Gynaecological... and other collaborators

Active, not recruiting

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response

United States, United Kingdom, Korea, Republic of, Russian Federation, Canada, Denmark, Taiwan, New Zealand, Ireland, Japan, Spain, Australia, Israel, Italy, Greece, Sweden, Czechia, Finland, Poland, Belgium, Germany, Romania, Singa... and more
University of Turku
Helsinki University Central Hospital

Completed

Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy

Self Care | Patient Empowerment | Cancer of Colon | Cancer of Rectum | Patient Activation

Finland
Boneca Corporation

Terminated

Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer

Head and Neck Cancer

Finland
Turku University Hospital

Recruiting

Exercise and Tumor Blood Flow in Breast Cancer Patients (EXETUMOR2)

Cancer, Breast

Finland
Kancera AB
LINK Medical Research AB; CRST Oy; Q&Q Labs AB

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145

Ovarian Cancer

Finland

Clinical Trials on Fallopian Cancer in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations